1) pharmacophore
['fɑ:məkəfɔ:]
药效基团
1.
Overview of studies on the anti-tumour pharmacophore of traditional Chinese medicines;
中药抗肿瘤有效成分的药效基团研究概况
2.
Present paper elucidates the following aspects; evolution of chemical classes of insecticides that act on insect nAChRs, structure and function of nAChRs, structure - activity of nicotine analogs, the structure modified and selectivity of neonicotinoid insecticides, and the pharmacophore of neonicotinoids.
本文就以下几方面作了详细的阐述:作用于昆虫nAChRs的各类化学杀虫剂的演绎,nAChRs的结构与活性,烟碱类似物的结构与活性,新烟碱类杀虫剂的结构修饰及其选择性,以及新烟碱类的药效基团。
3.
Functional fragments contain structural elements known as pharmacophores which generate the bioactivity of the drugs,while structural fragments assemble the functional fragments into a specific skeleton also crucial for the activity.
功能性分子片段包含药物产生生物活性所必须的结构单元(简称药效基团);而结构性分子片段则是将功能性分子片段连接起来从而形成特定结构的分子骨架。
2) Pharmacophore
['fɑ:məkəfɔ:]
药效基团模型
3) pharmacophore
['fɑ:məkəfɔ:]
药效团
1.
3D-QSAR and Pharmacophore Modeling of Growth Hormone Secretagogues;
促生长激素释放素三维定量构效关系及药效团模型
2.
Strategy of molecular drug design:pharmacophore and scaffold hopping;
药物分子设计的策略:论药效团和骨架迁越
3.
Study of concerted mechanism between P-glycoprotein and cytochrome P4503A4 by 3D-pharmacophore modeling;
基于3D-药效团的P糖蛋白和细胞色素P4503A4的协同作用机理研究
4) Pharmacophore model
药效团模型
1.
3D - database searching based on pharmacophore model of protox inhibitors;
利用原卟啉原氧化酶抑制剂药效团模型进行数据库搜索
2.
3D-database searching based on ALS inhibitors' pharmacophore model;
基于ALS抑制剂药效团模型的数据库搜索
3.
Construction of pharmacophore model of PARP-1 inhibitor;
聚腺苷二磷酸核糖聚合酶-1抑制剂药效团模型的建立
5) pharmacophore
['fɑ:məkəfɔ:]
三维药效团
1.
Pharmacophore Model Generation of HMG-CoA Reductase Inhibitors;
HMG-CoA还原酶抑制剂三维药效团的构建
2.
In the process of the rational screening on neuramidinase(NA)inhibitors of influenza virus,there were 4 stages:1)Prepared for drug-like compound database;2)Established 3D pharmacophore model of NA inhibitors and searched con-formations in the target compound database;3)Selected the compounds by the result of molecular docking and did post-docking analysis.
介绍了理性筛选流感病毒神经氨酸酶抑制剂的全过程,共分4个阶段:1)化合物数据库类药性处理;2)建立神经氨酸酶抑制剂三维药效团并对目标数据库进行构象搜索;3)分子对接及对接后分析;4)神经氨酸酶抑制模型的建立及待测化合物的活性检测。
6) pharmocophore determination
药效团确定
补充资料:附着剂可提高蜡质蔬菜药效
| |
©2011 dictall.com |